公开(公告)号：US20080121481A1

公开(公告)日：2008-05-29

申请号：US11873063

申请日：2007-10-16

申请人： Hiroaki MITSUHASHI ,  Hiroyuki HASHIMOTO

发明人： Hiroaki MITSUHASHI ,  Hiroyuki HASHIMOTO

IPC分类号： B60L9/00

CPC分类号： H02J3/005 ,  H02J5/005 ,  H02J50/10

摘要： An object of the present invention is to provide a non-contact electricity feeding facility that feeds electricity to a rail guided vehicle in a non-contact manner, the facility enabling a temperature abnormality in a feeding cable to be reliably detected using a simple configuration. The present invention provides a non contact electricity feeding facility 7 that feeds electricity to a rail guided vehicle 5 in a non-contact manner, the facility including a thermostat 43 mounted at an end of the feeding cable 9 at a connection between a feeding cable 9 and a bus bar 12 for junction or termination which is required for feeding electricity, the thermostat 43 operating at least a predetermined temperature, and a temperature abnormality detecting circuit 44 that detects that the thermostat 43 has operated.

摘要翻译： 本发明的目的是提供一种以非接触方式向轨道导引车辆供电的非接触供电装置，能够使用简单的结构可靠地检测供电电缆的温度异常的设备。 本发明提供一种以非接触方式向轨道导向车辆5供电的非接触供电设备7，该设备包括安装在供电电缆9的端部处的馈电电缆9 以及用于馈电所需的接合或终端的母线12，至少运行预定温度的恒温器43以及检测恒温器43已经操作的温度异常检测电路44。

公开(公告)号：US6028208A

公开(公告)日：2000-02-22

申请号：US242665

申请日：1999-02-22

申请人： Qingzhi Gao ,  Kenji Manabe ,  Minoru Furuya ,  Manabu Chokki ,  Hiroaki Mitsuhashi ,  Seiichi Ishizuka ,  Tadashi Kishimoto ,  Masayasu Tabe ,  Yasuji Sakuma ,  Atsuo Hazato ,  Hiroko Tanaka

发明人： Qingzhi Gao ,  Kenji Manabe ,  Minoru Furuya ,  Manabu Chokki ,  Hiroaki Mitsuhashi ,  Seiichi Ishizuka ,  Tadashi Kishimoto ,  Masayasu Tabe ,  Yasuji Sakuma ,  Atsuo Hazato ,  Hiroko Tanaka

IPC分类号： C07C401/00 ,  A61K31/59

CPC分类号： C07C401/00

摘要： Provided are vitamin D.sub.3 derivatives expressed by the following general formula [1] ##STR1## [wherein, R.sub.1 and R.sub.2 are each a hydrogen atom, a trialkylsilyl group, an acetyl group, a methoxymethyl group, or a tetrahydropyranyl group; R.sub.3 and R.sub.4 are each a hydrogen atom, a hydroxyl group, an acyloxy group, an alkyloxy group, an alkylthio group or an alkyl group which is optionally substituted; R.sub.5, R.sub.6, R.sub.7 and R.sub.8 are each a hydrogen atom, a hydroxyl group, an alkyl group or an acyloxy group; R.sub.9 is a hydrogen atom, a hydroxyl group, an alkyl group or an alkylthio group; R.sub.10 is a hydrogen atom, an alkyl group or an alkyloxy group; A and B are each a hydrogen atom, a hydroxyl group, or together express a single bond; X and Y express a carbonyl oxygen, or one of them is a hydrogen atom and the other is a hydroxyl group or an acyloxy group; n is an integer of 0 to 2; m is an integer of 0 to 2], and a method for manufacturing the derivatives.The compounds can be sued as active ingredients of treating agents for inflammatory respiratory diseases, malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis and dermatitis.

摘要翻译： PCT No.PCT / JP98 / 02813 Sec。 一九九九年二月二十二日 102（e）1999年2月22日PCT提交1998年6月24日PCT公布。 公开号WO98 / 58909 日期：1998年12月30日提供由以下通式[1]表示的维生素D3衍生物[其中，R1和R2各自为氢原子，三烷基甲硅烷基，乙酰基，甲氧基甲基或四氢吡喃基; R3和R4各自为氢原子，羟基，酰氧基，烷氧基，烷硫基或任选取代的烷基; R5，R6，R7和R8分别是氢原子，羟基，烷基或酰氧基; R9为氢原子，羟基，烷基或烷硫基; R 10是氢原子，烷基或烷氧基; A和B各自为氢原子，羟基，或一起表示单键; X和Y表示羰基氧，或者其中一个是氢原子，另一个是羟基或酰氧基; n为0〜2的整数， m为0〜2的整数]，以及该衍生物的制造方法。 这些化合物可以作为炎性呼吸系统疾病，恶性肿瘤，类风湿性关节炎，骨质疏松症，糖尿病，高血压，脱发，痤疮，牛皮癣和皮炎的治疗剂的活性成分。

公开(公告)号：US06676968B1

公开(公告)日：2004-01-13

申请号：US09889487

申请日：2001-07-18

申请人： Kiyoyuki Sakon ,  Masahiko Narasaki ,  Kentaro Fujinaga ,  Yoji Yamamoto ,  Hiroaki Mitsuhashi ,  Kazuoki Tsuruta ,  Hirofumi Tanabe ,  Yoshiaki Igarashi

发明人： Kiyoyuki Sakon ,  Masahiko Narasaki ,  Kentaro Fujinaga ,  Yoji Yamamoto ,  Hiroaki Mitsuhashi ,  Kazuoki Tsuruta ,  Hirofumi Tanabe ,  Yoshiaki Igarashi

IPC分类号： A61K922

CPC分类号： C07D211/26

摘要： A medicinal composition containing one or more compounds selected from the compounds represented by the following formula (I), salts of these compounds, solvates of these compounds and solvates of these salts and being capable of reducing the contact of the compounds with the components in the bile or pancreatic juice.

摘要翻译： 一种含有一种或多种选自下式（I）表示的化合物，这些化合物的盐，这些化合物的溶剂合物和这些盐的溶剂化物并能够减少化合物与组分的接触的药物组合物 胆汁或胰液

公开(公告)号：US5792712A

公开(公告)日：1998-08-11

申请号：US737932

申请日：1996-12-03

申请人： Shoji Hori ,  Satoru Toyoshima ,  Junichi Yamanaka ,  Akira Kawabata ,  Hiroaki Mitsuhashi ,  Yukio Ushiya ,  Masayuki Yamada

发明人： Shoji Hori ,  Satoru Toyoshima ,  Junichi Yamanaka ,  Akira Kawabata ,  Hiroaki Mitsuhashi ,  Yukio Ushiya ,  Masayuki Yamada

IPC分类号： A01N25/34 ,  A01N59/04 ,  A47L23/26 ,  A61L2/18 ,  A47L23/22 ,  A01N59/00 ,  A61L2/16

CPC分类号： A61L2/18 ,  A01N25/34 ,  A01N59/04 ,  A47L23/266 ,  Y10T428/23986 ,  Y10T442/2033 ,  Y10T442/2525

摘要： The present invention relates to a microbiocidal mat to be installed at the entrance of a clean zone in a biochemical plant, a hospital or a like facility, the mat comprising a mat body 1 containing an alkaline compound 5 as a microbicide. The mat body may further contain a surface active agent and/or a water-retentive agent, the water-retentive agent comprising a substance which is stable against water and has deliquescence. Where the mat body 1 contains the compound and the agents in powdery crystallized states, the mat body 1 is used in a wet state by supplying water thereto after the mat is installed at the entrance. When the mat body 1 is supplied with water, the alkaline compound is dissolved in water within the mat body 1 so that the mat body 1 is imparted with microbiocidal activity. A method of manufacturing such a mat comprises the steps of: impregnating the mat body 1 with an aqueous solution of the contained substances, and drying the mat body 1 to cause the contained substances to crystallize in the mat body 1.

摘要翻译： PCT No.PCT / JP96 / 00902 Sec。 371日期1996年12月3日第 102（e）日期1996年12月3日PCT PCT 1996年4月1日PCT公布。 WO96 / 31153 PCT出版物 日期：1996年10月10日本发明涉及一种要安装在生化厂，医院等设施的清洁区入口处的杀微生物垫，该垫包括含有碱性化合物5作为杀微生物剂的垫体1 。 垫体可以进一步含有表面活性剂和/或保水剂，该保水剂包含对水稳定且具有潮解性的物质。 在垫体1包含化合物和粉末状结晶状态的试剂的情况下，垫子1在垫被安装在入口处之后通过向其供水而使用。 当垫体1被供给水时，碱性化合物溶解在垫体1内的水中，使得垫体1具有杀微生物活性。 制造这种垫的方法包括以下步骤：用所含物质的水溶液浸渍垫体1，并干燥垫体1以使所含的物质在垫体1中结晶。